Randox unveils Future of Diagnostics Technology at Annual Global Distributors’ Conference
The future of diagnostic healthcare has been unveiled at the Randox Science Park in Antrim, as the company’s annual global distributors’ conference gets underway. Delegates from more than 90 countries are taking part in the world-leading healthcare firm’s three-day event at the Hilton Hotel in Templepatrick.
As well as discussions about developments in reagents and quality control products, participants enjoyed demonstrations of Randox’s patented Biochip Array Technology and its extensive range of analysers from the RX Series.
Melansha Fernando from Alpha and Omega Diagnostics in Sri Lanka said,
“Randox has released so many new products recently that laboratories in my country are increasingly interested in what it can offer. As a result I felt it important to come here to learn more about the new technologies. The truly global nature of the company has been impressed upon me after meeting colleagues from so many different countries – I’m delighted to have been able to take part.”
Speaking at the conference, Dr. Peter Fitzgerald said,
“All exporters are aware of the considerable challenges we must overcome in order to do business in the global market but year on year our teams across the world have helped to drive our success. One of the biggest challenges Randox faces is the one we put to ourselves, to deliver truly transformative technologies and improve health worldwide. We recently celebrated our £1 billionth sale and we now look to build on that achievement and accelerate our rate of growth. All of our profits go straight to either R&D, or the development of our infrastructure, so strong growth is key to our goal of revolutionising diagnostics and saving lives across the world.”
Susan Hammond, Global Reagents Sales Manager said,
“It is a pleasure to see the diversity of our distributors gathered together in one room, and recognize how far we have come as an international company. We dedicated Thursday to focusing on building relationships with our worldwide distributors to ensure that they attain the best product knowledge available. Over 100,000 end users employ Randox products and every second of every day 80 Randox tests are used across the world, and it is vital our distributors are kept up to date with every new development.”
For more information on the Distributors’ Conference contact Amy in our PR Team by calling 028 9445 1016 or email email@example.com
Leading clinical diagnostics company Randox is delighted to have been selected as a ‘Ruban D’Honneur’ winner for imports/exports in the prestigious European Business Awards 2014/15.
Having gone head to head with some of the biggest business names in Europe, this esteemed award recognises Randox as one of the most dynamic and exciting businesses in Europe, lauding Randox’s success in imports/exports across the Globe.
From its headquarters in Crumlin Co. Antrim, Randox has grown into an international success story, at the frontline of improving health in conditions such as stroke, dementia, diabetes, heart disease, STI’s and respiratory infections through earlier and more accurate diagnosis.
Every year a staggering 350 million people – 5% of the world’ population – are diagnosed with Randox products. Randox supplies 10% of the world’s cholesterol tests, and 8% of all clinical chemistry tests undertaken globally. In being shortlisted as one of ten European winners, the importance of Randox successful global export strategy has been recognised.
Randox are striding forward: driven by innovation and a commitment to saving lives, Randox currently has more clinical diagnostic tests in development than any other company in the world. Randox recently announced ambitious plans to develop Randox Science Park in Antrim – a centre for excellence in clinical research & development, engineering and transformative health.
Dr Peter FitzGerald, Managing Director of Randox said:
“We are delighted to have won this prestigious award, in recognition of our key objective – to save lives globally. Our success is built on world-class, innovative products which enable earlier, more accurate diagnosis. Randox products improve the quality of life and enhance the efficiency of healthcare, saving lives right across the world. This award is clear recognition of the difference Randox can make to health globally.”
Leading clinical diagnostics firm Randox Laboratories goes head to head with some of the biggest brands in the UK, as it competes for the title of ‘National UK Champion’ in the European Business Awards 2015.
Randox, having already faced stiff competition from across the UK to be shortlisted as a National Champion, will now face the public vote and are asking you to put health at the frontline by supporting them.
Randox will be judged by the public from a company video which gives a powerful and inspiring insight into the story of Randox.
From its headquarters in Crumlin Co Antrim, Randox has grown into an international success story, at the frontline of improving health in conditions such as stroke, dementia, diabetes, heart disease, STI’s and respiratory infections through earlier and more accurate diagnosis.
Every year a staggering 350 million people – 5% of the world’s population – are diagnosed with Randox products. Randox supplies 10% of the world’s cholesterol tests, and 8% of all clinical chemistry tests undertaken globally: the chances are if you’ve ever had blood taken by a doctor it’s been assessed using a Randox product.
Randox aren’t standing still: driven by innovation and a commitment to saving lives, Randox currently has more clinical diagnostic tests in development than any other company in the world.
Why vote for Randox? Dr Peter Fitzgerald, Managing Director of Randox says:
“Randox’s key driver is to save lives. Our raison d‘etre is to improve health not just here in Northern Ireland but right across the world. Our success is built on world-class, innovative products which enable earlier, more accurate diagnosis. In doing so we improve the quality of life, enhance the efficiency of healthcare and save lives, globally.”
Randox will compete against other UK shortlisted Champions for the public vote. The company with the most votes will be named the UK’s ‘National Public Champion’ on 3rd March 2015. From this, National Champions will have the opportunity to compete with winners from across Europe to earn the highly acclaimed title of ‘European Public Champion’ at a glittering Awards Gala event in May 2015.